CLASS II ONGOING Device recall · Reported 14 Aug 2024 · FDA Enforcement Report

CryoPatch SG Pulmonary Human Cardiac Hemi-Artery recalled by Artivion

Artivion is recalling CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch Cryopreserved, distributed nationwide in the US. The recall was initiated on 28 May 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes(1) SGPH00 - Serial #12071128, exp. 17Nov2027; and serial #11586249, exp. 04May2025; UDI-DI: 00877234000461. (2) SGP020 - Serial #12658767, exp. 15Aug2028; UDI-DI: 00877234000485.
Quantity recalled2 arteries, 1 patch

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2532-2024
FDA event ID
94909
Recalling firm
Artivion, Kennesaw, GA
Classification
Class II
Status
Ongoing
Recall initiated
28 May 2024
FDA classified
8 Aug 2024
Reported
14 Aug 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

28 May 2024Recall initiated by company
8 Aug 2024Classified by FDA+72 days
14 Aug 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Grafts were found to have been approved, released, shipped and implanted with an invalid test results.

Product as listed by the FDA

(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology; and (2) CryoPatch SG Pulmonary Human Cardiac Branch Patch, SGP020, Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology.

Where it was distributed

US Nationwide distribution in the states of CA, DC, FL, and NY.

Nationwide CaliforniaDistrict of ColumbiaFloridaNew York

Questions about this recall

Why was it recalled?

Grafts were found to have been approved, released, shipped and implanted with an invalid test results.

Which lots are affected?

(1) SGPH00 - Serial #12071128, exp. 17Nov2027; and serial #11586249, exp. 04May2025; UDI-DI: 00877234000461. (2) SGP020 - Serial #12658767, exp. 15Aug2028; UDI-DI: 00877234000485.

Where was it sold?

US Nationwide distribution in the states of CA, DC, FL, and NY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 94909
ReportedClassRecallCompanyReasonWhere
CLASS IICryoValve SG Pulmonary Human Heart Valve, SGPV00 recalled by ArtivionArtivionOtherNationwide

More recalls from Artivion

All 3

Other Other Medical Devices recalls

All 13,778